Therapeutic effect of intravitreal anti-VEGF drugs on retinal neovascularization in diabetic retinopathy

MeSH terms

• Angiogenesis Inhibitors* / administration & dosage
• Angiogenesis Inhibitors* / therapeutic use
• Antibodies, Monoclonal, Humanized / administration & dosage
• Antibodies, Monoclonal, Humanized / therapeutic use
• Bevacizumab* / administration & dosage
• Bevacizumab* / therapeutic use
• Diabetic Retinopathy* / drug therapy
• Female
• Humans
• Intravitreal Injections*
• Male
• Ranibizumab* / administration & dosage
• Ranibizumab* / therapeutic use
• Retinal Neovascularization* / drug therapy
• Retinal Neovascularization* / etiology
• Vascular Endothelial Growth Factor A* / antagonists & inhibitors